Semen Analysis

Semen Analysis Market Outlook

The global semen analysis market is anticipated to reach approximately USD 2.5 billion by 2035, growing at a CAGR of around 8.5% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing prevalence of infertility issues among couples, rising awareness regarding male reproductive health, and a growing number of sperm banks and fertility clinics. Furthermore, advancements in laboratory technologies and the integration of artificial intelligence in semen analysis are also expected to contribute significantly to market expansion. The rise in lifestyle-related issues such as obesity, smoking, and stress has led to a surge in male reproductive disorders, thus amplifying the demand for semen analysis tests. As the healthcare industry evolves with a focus on personalized medicine, the semen analysis market is set to witness further innovations to cater to the diverse needs of patients and healthcare providers alike.

Growth Factor of the Market

The growth of the semen analysis market can be attributed to a combination of societal, technological, and economic factors. With increasing awareness about male infertility and reproductive health, there is a rising demand for semen analysis tests among men seeking to understand their reproductive health better. Moreover, the acceptance of assisted reproductive technologies (ART) and the establishment of reproductive health clinics play a significant role in driving demand. Advances in laboratory testing techniques, including the use of automated systems and artificial intelligence, enhance the accuracy and efficiency of semen analysis, making them more appealing to healthcare providers. Government initiatives and investments aimed at improving healthcare infrastructure also support the growth of this market by making services more accessible. Additionally, the rising number of lifestyle-related disorders that affect fertility, such as diabetes and hormonal imbalances, creates a compelling need for comprehensive semen analysis services.

Key Highlights of the Market

• The global semen analysis market is expected to see significant growth due to rising male infertility rates.
• Technological advancements are leading to increased accuracy and efficiency in semen analysis tests.
• Fertility clinics are emerging as key end-users driving demand for semen analysis services.
• Increased awareness of male reproductive health is encouraging more men to seek semen analysis.
• Geographically, North America holds a significant share of the semen analysis market due to advanced healthcare facilities.

By Test Type

Sperm Count:

Sperm count testing is one of the most fundamental components of semen analysis, providing crucial data regarding the number of spermatozoa present in a given semen sample. An optimal sperm count is vital for fertility, as it directly affects the chances of successful conception. Rising infertility rates globally have intensified the focus on sperm count tests, as they offer significant insights into male fertility potential. Additionally, advancements in laboratory technology have improved the precision of these tests, allowing for better detection of suboptimal levels. As men become more proactive about their reproductive health, the demand for sperm count testing is expected to increase significantly, making it a pivotal segment within the semen analysis market.

Motility:

Motility testing is crucial in semen analysis, as it assesses the movement and vitality of sperm. Healthy motility rates are essential for sperm to successfully navigate through the female reproductive tract to fertilize the egg. Various factors, including lifestyle, environmental pollutants, and health conditions, can affect motility rates, leading to increased interest in testing among individuals experiencing fertility issues. The growing understanding of the importance of sperm motility in reproductive success has prompted more couples to seek comprehensive semen analysis, driving growth in this segment. With continuous advancements in motility analysis techniques, such as computer-assisted sperm analysis (CASA), the accuracy and efficiency of these tests have improved significantly, attracting more customers and healthcare providers alike.

Morphology:

Morphology testing examines the shape and structure of sperm cells, which is critical for assessing their functionality and potential for fertilization. Abnormal sperm morphology can hinder the process of conception, making this test an essential component of semen analysis. Technological innovations, such as high-resolution microscopy and automated sperm analysis systems, have enhanced the ability to evaluate sperm morphology accurately. There is an increasing recognition of the role sperm morphology plays in male fertility, leading to a surge in demand for this type of testing. As more men become educated about their reproductive health, the morphology segment of the semen analysis market is expected to experience significant growth in the coming years.

Volume:

The volume of semen produced during ejaculation is an important parameter in semen analysis, as it can indicate potential reproductive health issues. Adequate semen volume is necessary for optimal sperm concentration and overall fertility. The growing prevalence of male infertility prompted by various lifestyle factors has led to a heightened interest in volume testing. Healthcare professionals often utilize volume assessments in conjunction with other semen parameters to gain a comprehensive understanding of male reproductive health. Advances in testing methodologies and increased access to fertility services are likely to drive growth in this segment of the market as more men seek evaluations for their reproductive capabilities.

Vitality:

Sperm vitality testing measures the percentage of live sperm in a semen sample, which is a critical indicator of male fertility. A high percentage of viable sperm is essential for successful fertilization, making this test a vital part of semen analysis. Factors such as temperature exposure, environmental toxins, and lifestyle choices can negatively impact sperm vitality. With increased awareness of male reproductive health and rising infertility rates, more individuals are seeking semen analysis services that include vitality testing. The growth of this segment is further supported by advancements in laboratory techniques that provide accurate and rapid assessments of sperm vitality, ensuring timely and effective treatment options for those facing infertility challenges.

By End User

Hospitals:

Hospitals are significant end-users of semen analysis services, given their comprehensive medical facilities that cater to various health conditions, including infertility. Many hospitals have specialized departments for reproductive health, where semen analysis is conducted as part of fertility assessments. The increasing prevalence of infertility issues and the subsequent demand for diagnostic services have led hospitals to expand their offerings in this area. Additionally, hospitals often have access to advanced technologies that enhance the accuracy of semen analysis, providing patients with reliable results. As more couples seek assistance for fertility challenges, hospitals are poised to remain key players in the semen analysis market, contributing significantly to overall growth.

Fertility Clinics:

Fertility clinics represent a crucial segment in the semen analysis market, providing specialized services tailored to individuals facing reproductive challenges. These clinics often offer a range of reproductive health services, including semen analysis, in vitro fertilization (IVF), and other assisted reproductive technologies. The rise in infertility rates and the increasing awareness of reproductive health have led to the establishment of numerous fertility clinics worldwide, further driving demand for semen analysis. Additionally, fertility clinics often employ advanced testing techniques and technologies that enhance the accuracy and efficiency of semen analysis, making them a preferred choice for many individuals seeking fertility evaluations. As the focus on reproductive health continues to grow, fertility clinics are expected to play a vital role in shaping the future of the semen analysis market.

Diagnostic Laboratories:

Diagnostic laboratories are instrumental in providing semen analysis services, leveraging their expertise in testing and diagnostics to deliver accurate results. These laboratories often collaborate with healthcare providers, fertility clinics, and hospitals to offer comprehensive semen analysis as part of a broader range of diagnostic services. The rise in male infertility awareness and the demand for accurate testing have propelled the growth of diagnostic laboratories specializing in semen analysis. Additionally, advancements in laboratory technologies enable these facilities to conduct tests more efficiently, improving turnaround times for results. As healthcare trends shift towards more specialized and accurate testing methods, diagnostic laboratories are expected to continue expanding their role in the semen analysis market.

Research Institutes:

Research institutes play a significant role in advancing the field of reproductive health, including semen analysis. These institutions are often at the forefront of scientific research, exploring new methodologies and technologies to improve the accuracy and efficiency of semen analysis tests. As the demand for evidence-based practices in reproductive health grows, research institutes contribute by providing data and insights that inform clinical practices. Collaborations between research institutes and healthcare facilities can lead to innovations in semen analysis and foster the development of more effective treatments for male infertility. The ongoing commitment to research and development in this domain is expected to drive growth in the semen analysis market as new discoveries are translated into clinical applications.

Others:

This category encompasses various end-users, such as private clinics, wellness centers, and alternative medicine practices that may offer semen analysis services. As male reproductive health gains more attention, alternative health providers are increasingly incorporating semen analysis into their service offerings to cater to health-conscious individuals. The growing awareness of reproductive health and the importance of semen analysis among diverse populations further fuel demand across this segment. Additionally, convenient access to these services in non-traditional settings is likely to attract more individuals interested in understanding their reproductive health. As societal attitudes towards male fertility continue to evolve, the "Others" category in the end-user segment is poised for growth, contributing to the overall expansion of the semen analysis market.

By Component

Instruments:

Instruments utilized in semen analysis are critical as they directly impact the accuracy and reliability of the tests performed. These include various laboratory equipment such as microscopes, sperm analyzers, and centrifuges specifically designed for analyzing semen samples. Technological advancements in instrumentation have led to the development of automated systems that significantly enhance testing efficiency and results' precision. The increasing demand for high-quality semen analysis is primarily driving the growth of this segment. As healthcare professionals strive to improve the accuracy of diagnostic results, investments in advanced instruments will likely continue to grow, further propelling this segment of the market.

Reagents & Kits:

Reagents and kits are essential components of semen analysis, providing the necessary materials for conducting various tests. The market for these products is driven by the increasing demand for accurate and efficient semen analysis in clinical settings. Reagents used in sperm analysis often undergo stringent quality control measures to ensure reliability and consistency in results. The rise in the number of fertility clinics and diagnostic laboratories has contributed to a growing demand for high-quality reagents and kits tailored for semen analysis. As healthcare providers increasingly emphasize the importance of accurate testing in reproductive health, the reagents and kits segment is expected to experience significant growth in the coming years.

Software:

Software solutions play a vital role in the semen analysis market by facilitating data management, interpretation, and reporting from semen tests. Advanced software applications designed for semen analysis allow healthcare professionals to analyze test results efficiently and accurately. Additionally, the integration of artificial intelligence and machine learning into these software applications enhances the ability to interpret complex data and provide actionable insights. As laboratories and clinics seek to automate their processes and improve operational efficiency, the demand for software solutions in semen analysis is expected to rise. The trend towards digitization in healthcare further supports the growth of this segment, as more providers adopt technology-driven solutions for comprehensive semen analysis.

By Service Type

Routine Semen Analysis:

Routine semen analysis involves standard testing procedures to evaluate basic parameters such as sperm count, motility, morphology, and volume. This type of analysis is typically the first step in assessing male fertility and is essential for couples experiencing difficulties in conceiving. With the increasing prevalence of infertility issues, the demand for routine semen analysis services is on the rise. Healthcare providers emphasize the importance of these tests in providing a preliminary assessment of male reproductive health, enabling timely interventions if needed. The routine semen analysis segment is expected to witness consistent growth as more individuals seek assistance in understanding their reproductive capabilities.

Advanced Semen Analysis:

Advanced semen analysis incorporates additional testing methods and technologies to provide a comprehensive evaluation of male fertility beyond the routine parameters. This may include tests for sperm DNA fragmentation, advanced motility assessments, and functional tests that gauge the overall health of sperm. The growing demand for personalized fertility assessments drives the need for advanced semen analysis services among couples seeking to conceive. As reproductive health gains prominence, more healthcare providers offer advanced testing options to address unique patient needs, leading to the expansion of this segment. Innovations in testing methodologies and technologies will likely continue to enhance the offerings in advanced semen analysis, catering to an increasingly informed patient population.

Sperm DNA Fragmentation:

Sperm DNA fragmentation testing is a specialized analysis that evaluates the integrity of sperm DNA, which is crucial for successful fertilization and embryo development. High levels of DNA fragmentation may be linked to failed fertilization or increased miscarriage rates, making this test significant in fertility assessments. As awareness of male reproductive health grows, more couples are seeking this advanced analysis to better understand their fertility challenges. The integration of sophisticated technologies in sperm DNA fragmentation testing has improved its accessibility and accuracy, driving demand for this service. Ultimately, the sperm DNA fragmentation segment is expected to see substantial growth as it becomes an essential component of comprehensive fertility evaluations.

By Region

The North American region holds a substantial share in the semen analysis market, projected to reach approximately USD 900 million by 2035, with a CAGR of around 9% during the forecast period. This growth is driven by the advanced healthcare infrastructure, widespread availability of fertility clinics, and increased awareness regarding male reproductive health. Additionally, policy initiatives and support for reproductive health services in this region contribute to its leading position in the global market. The United States, in particular, is at the forefront of research and development in reproductive health technologies, further solidifying North America's dominance in the semen analysis market.

In Europe, the semen analysis market is anticipated to witness robust growth, with an estimated market size of around USD 750 million by 2035. Factors such as the rising incidence of infertility, growing acceptance of assisted reproductive technologies, and increasing investments in healthcare infrastructure contribute to this growth. The region benefits from a well-established network of fertility clinics and diagnostic laboratories that provide comprehensive semen analysis services. Countries like Germany and the United Kingdom are expected to account for significant shares within the European market as they continue to prioritize advancements in reproductive health and fertility treatments. Overall, the European region is set to play a vital role in the ongoing development of the global semen analysis market.

Opportunities

The semen analysis market presents numerous opportunities for growth, especially in the context of increasing public awareness of male reproductive health. As society becomes more open about discussing fertility issues, more individuals are likely to seek assistance for their reproductive challenges. This cultural shift, combined with the growing acceptance of assisted reproductive technologies, creates significant potential for market expansion. Furthermore, advancements in technology and testing methods provide fertile ground for innovation, allowing companies to develop improved semen analysis solutions that cater to diverse patient needs. The increasing number of fertility clinics and sperm banks also represents an opportunity for collaborations and partnerships aimed at providing comprehensive reproductive health services, helping to drive the market forward. Additionally, the emergence of telemedicine and remote consultation services can facilitate access to semen analysis, further widening the customer base and enhancing market growth potential.

Another opportunity lies in the rising prevalence of lifestyle-related factors affecting male fertility. As conditions like obesity, stress, and substance abuse contribute to reproductive health issues, the demand for semen analysis services is expected to rise. Healthcare providers can leverage this opportunity by offering awareness campaigns and educational resources on the importance of semen analysis in assessing male fertility. Collaborations between healthcare providers and research institutions can lead to the development of innovative testing methods and interventions that address these lifestyle factors, contributing to market growth. As the global focus on reproductive health continues to evolve, the semen analysis market stands to benefit from ongoing research, development, and awareness initiatives aimed at improving male fertility outcomes.

Threats

Despite its growth potential, the semen analysis market faces several threats that could hinder its expansion. One major challenge is the lack of awareness and understanding of male infertility among the general population, which may deter men from seeking necessary testing and evaluations. Cultural stigmas surrounding male reproductive health can also play a significant role in limiting demand for semen analysis services. Additionally, the market is subject to stringent regulations and standards that may complicate the development and approval of new testing technologies. These regulatory challenges can slow innovation and limit the introduction of advanced methodologies that could enhance the accuracy and efficiency of semen analysis. Furthermore, competition from alternative diagnostic methods and the emergence of home-testing kits pose a threat to traditional semen analysis services, potentially disrupting established market dynamics.

Another concern for the semen analysis market is the potential for fluctuations in healthcare funding and reimbursement rates. Economic downturns or changes in government policies may lead to reduced financial support for reproductive health services, negatively impacting both providers and patients. This situation could result in decreased investments in semen analysis technologies and services, ultimately hampering market growth. Additionally, as the healthcare landscape evolves with the integration of digital health solutions, traditional semen analysis providers may face challenges in adapting to meet the demands of an increasingly tech-savvy customer base. To thrive in this competitive environment, stakeholders in the semen analysis market must remain agile and responsive to emerging trends and challenges, ensuring that they continue to meet the needs of patients and healthcare providers alike.

Competitor Outlook

• Thermo Fisher Scientific
• Beckman Coulter, Inc.
• BD (Becton, Dickinson and Company)
• Spermatrace
• Fertility Focus
• Merck KGaA
• Vitrolife AB
• Irvine Scientific
• CooperSurgical, Inc.
• Fertility Specialists Medical Group
• Nantong Huakang Pharmaceutical Co., Ltd.
• Coral Gables Fertility Center
• ReproSource
• Reproductive Health Technologies
• Genea Limited

The competitive landscape of the semen analysis market is characterized by a diverse range of players, including established companies and emerging startups. Key market participants are continuously innovating and expanding their product offerings to meet the growing demand for semen analysis services. The focus on technological advancements, such as automated testing systems and AI-driven solutions, is driving competition among industry leaders. Companies are increasingly investing in research and development to enhance the accuracy and efficiency of semen analysis, allowing them to gain a competitive edge in this fast-evolving market. Furthermore, strategic collaborations between healthcare providers and technology firms are contributing to the development of innovative solutions that cater to the specific needs of patients and practitioners alike.

Key companies in the semen analysis market, such as Thermo Fisher Scientific and Beckman Coulter, are known for their extensive product portfolios and strong presence in the reproductive health sector. Thermo Fisher Scientific offers a wide range of advanced instruments and reagents specifically designed for semen analysis, enabling healthcare providers to perform comprehensive evaluations of male fertility. The company's commitment to innovation and technology-driven solutions positions it as a leader in the market. Similarly, Beckman Coulter provides a robust lineup of instruments and software solutions for semen analysis, focusing on enhancing laboratory efficiency and accuracy. As demand for reliable semen analysis continues to grow, these companies are well-positioned to capitalize on emerging opportunities and maintain their competitive edge.

Emerging players, such as Fertility Focus and Spermatrace, are also making a mark in the semen analysis market by introducing innovative products and services aimed at simplifying the testing process for both patients and healthcare providers. Fertility Focus, for example, has developed user-friendly home testing kits that allow men to assess their sperm health conveniently. This innovation addresses the growing demand for accessible and immediate testing options, appealing to a broader audience. Spermatrace focuses on providing real-time semen analysis solutions, leveraging advanced technology to enhance accuracy and efficiency. As the market evolves, these emerging players are expected to contribute to the dynamic landscape of the semen analysis sector, fostering competition and driving further advancements in reproductive health.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 ReproSource
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Spermatrace
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Vitrolife AB
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Genea Limited
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fertility Focus
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Irvine Scientific
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 CooperSurgical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Beckman Coulter, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Thermo Fisher Scientific
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Coral Gables Fertility Center
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Reproductive Health Technologies
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BD (Becton, Dickinson and Company)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fertility Specialists Medical Group
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Nantong Huakang Pharmaceutical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Semen Analysis Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Fertility Clinics
    • 6.1.3 Diagnostic Laboratories
    • 6.1.4 Research Institutes
    • 6.1.5 others
  • 6.2 Semen Analysis Market, By Component
    • 6.2.1 Instruments
    • 6.2.2 Reagents & Kits
    • 6.2.3 Software
  • 6.3 Semen Analysis Market, By Test Type
    • 6.3.1 Sperm Count
    • 6.3.2 Motility
    • 6.3.3 Morphology
    • 6.3.4 Volume
    • 6.3.5 Vitality
  • 6.4 Semen Analysis Market, By Service Type
    • 6.4.1 Routine Semen Analysis
    • 6.4.2 Advanced Semen Analysis
    • 6.4.3 Sperm DNA Fragmentation

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Semen Analysis Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Semen Analysis market is categorized based on

By Test Type

• Sperm Count
• Motility
• Morphology
• Volume
• Vitality

By End User

• Hospitals
• Fertility Clinics
• Diagnostic Laboratories
• Research Institutes
• others

By Component

• Instruments
• Reagents & Kits
• Software

By Service Type

• Routine Semen Analysis
• Advanced Semen Analysis
• Sperm DNA Fragmentation

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Beckman Coulter, Inc.
• BD (Becton, Dickinson and Company)
• Spermatrace
• Fertility Focus
• Merck KGaA
• Vitrolife AB
• Irvine Scientific
• CooperSurgical, Inc.
• Fertility Specialists Medical Group
• Nantong Huakang Pharmaceutical Co., Ltd.
• Coral Gables Fertility Center
• ReproSource
• Reproductive Health Technologies
• Genea Limited